Wednesday, 18 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Financial Results · Q3 2026

China Pharma Holdings Q3 2026 Results: Net Loss of $1.9M, Loss Widens

China Pharma Holdings reported a net loss of $4.5 million for the nine months ended September 30, 2026, compared to a $2.0 million loss in the prior year period. While revenue grew slightly to $3.1 million, the company faced significantly higher general and administrative expenses and a $0.5 million impairment loss.

Q3 2026 at a glance · $ million
MetricQ3 2026Q3 2025
Revenue1.20.8
Gross profit0.1-0.1
Profit before tax-1.9-0.7
Net income-1.9-0.7
EPS (diluted, $ a share)$-0.04$-0.17

A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.

Growth and margins
Revenue, year on year+52.5%
Gross margin8.0%
Operating margin-162.8%
Source

10-Q filed with the SEC, NYSE: CPHI. Figures from the filing's XBRL data; summary written with AI assistance from the filing.

Read the filing ↗

China Pharma Holdings, Inc.: key numbers

Share price
$0.5109Close, Nov 18
Market cap
$22M
Shares outstanding
43.02MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers, updated daily. Not a valuation or a recommendation.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.